There is some good news on Johnson & Johnson’s coronavirus vaccine as trials show even one dose of their vaccine is effective against the virus, reports CNN.
What the trial result shows?- Early results from a Phase 1/2a clinical trial show it was well tolerated and even one dose appeared to produce a strong immune response in almost all of the 800 participants.
- The trial included two age groups: 18- to 55-year-olds and 65 and older, and looked at the safety and side effects of two different doses.
https://mfame.guru/johnson-johnson-covid-vaccine-99-efficient-in-single-dose/